You Can
Save Up to $500*
on Gonal-f®

You already know infertility treatment can be expensive.
Don’t let cost keep you from seeking help.

FertilityAssist 2 from Fertility LifeLines™ can help you
save up to $500* on your second cycle of Gonal-f®.

Enrollment is easy

Ask your healthcare provider to enroll you in FertilityAssist 2. Then, fill your Gonal-f® prescription through Freedom Fertility Pharmacy™.

Save up to $500 on Gonal-f

For more information about FertilityAssist 2 speak to a Fertility LifeLines™ representative at 1-866-LETS-TRY (1-866-538-7879) or download the FertilityAssist2 Program Overview

You will need Adobe Flash Player to view this content.

  • The FertilityAssist2 program from Fertility LifeLines™ helped Lindsay afford treatment.

*Important eligibility information

Fill your cash prescription for Gonal-f® through Freedom Fertility Pharmacy™ for two cycles of treatment.

  • First cycle must contain a minimum of 900 IU
  • Second cycle must contain a minimum of 900 IU for a cash savings of $250 or a minimum of 2100 IU for a cash savings of $500
  • Enroll in FertilityAssist 2 between December 1, 2008 and June 30, 2010
  • Second prescription must be received and shipped by Freedom Fertility Pharmacy™ on or before September 30, 2010
  • Only one card may be redeemed at a time and cannot be used in conjunction with any other offer or discount program

Learn how FertilityAssist 2 helped Lindsay save on Gonal-f®.

Watch videos

FIND A FERTILITY SPECIALIST

Enter your Zip code to find a fertility treatment specialist or fertility clinic in your area:

FIND A UROLOGIST

The Society for the Study of Male Reproduction (SSMR) can help you locate a urologist in your area.

Locate a Urologist

Indication:
For women, Gonal-f® (follitropin alfa for injection), Gonal-f® RFF (follitropin alfa injection) and Gonal-f® RFF Pen (follitropin alfa injection) are indicated for 1) the induction of ovulation and pregnancy in the anovulatory infertile patient in whom the cause of infertility is functional and not due to primary ovarian failure and 2) for the development of multiple follicles in the ovulatory patient participating in an Assisted Reproductive Technology (ART) program.
For men, Gonal-f® is also indicated for the induction of spermatogenesis in men with primary and secondary hypogonadotropic hypogonadism in whom the main cause of infertility is not due to primary testicular failure.

Important Safety Information:
These products should only be prescribed by physicians specializing in fertility or reproductive health. Use of Gonal-f® or Gonal-f® RFF by women can result in multiple births. Patients should let their doctor know of any allergic reactions to recombinant FSH preparations or other product ingredients. Patients should also inform their doctor of a history of cancer of the sex organs or brain and uncontrolled thyroid or adrenal disease before starting or continuing treatment. Women with a history of abnormal bleeding from the uterus or vagina, swollen, enlarged, or painful ovaries should speak to their doctor before starting treatment. Gonal-f® and Gonal-f® RFF are potent gonadotropic substances capable severe adverse reactions, including Ovarian Hyperstimulation Syndrome (OHSS) in women, which can result hospitalization. Women should inform their doctor if they experience severe stomach pain, vomiting, bloating, or weight gain while taking Gonal-f® or Gonal-f RFF®. The most common side effects are headache, ovarian cysts, upset stomach, and sinus infections in women taking Gonal-f® or Gonal-f® RFF. The most common side effects in men taking Gonal-f® are skin acne, breast pain and growth, and tiredness. Needle injections may cause some discomfort.

For more information, refer to the prescribing and patient information offered below and talk to your doctor.


© EMD Serono, Inc. CIM Last Update 2008-09-16
This site contains medical information that is intended for residents of the United States only and is not meant to substitute for the advice provided by a medical professional. Always consult a physician if you have health concerns. Use and access of this site is subject to the terms and conditions as set out in our Legal Statement and Privacy Policy.

This site contains information that is intended for US residents only. Canadian residents should consult the EMD Serono Canada Inc. Web site at www.emdserono.ca for information on products and services approved in Canada.

EMD Serono

Close

Please wait... loading

View the Full Glossary
CLOSE

You will need Adobe Flash Player to view this content.